Hari is Chief Operating Officer of Tessera. He served as Operating Partner at Flagship Pioneering, where he grew Tessera from a NewCo to a GrowthCo. He cofounded Mirai Bio and was the Founding Presiden, and currently serves as a Board Director. He also serves as a Board Director on Ring Therapeutics. Hari is a global Biopharmaceutical executive with 25+ years of value creation in the biologics and vaccine industry. Before Flagship, Hari served as Chief Technology Officer of Spark Therapeutics, leading the technical operations, process and technology development and quality assurance organizations. Prior to Spark, Hari was head of Technical Development & Manufacturing at Moderna Therapeutics. Previously, Hari held a variety of scientific and cross-functional leadership positions during 18+ years at Merck & Co in the company’s commercial, R&D and manufacturing divisions, culminating in the franchise leadership of pediatric and adult vaccines representing over $2B in revenue. Hari has a Ph.D. in Chemical Engineering from the University of Delaware and an MBA from the Wharton School at the University of Pennsylvania. He is a Fellow of the American Chemical Society and the American Institute of Medical and Biological Engineers.